Hospital
Phc-Fort Mohave INC
Phc-Fort Mohave INC was paid $19.95M by Medicaid between Jan 2018 and Dec 2024, across 188 billing codes. Its largest line is 99284, emergency room visit (serious) — 23% of everything it billed.
33Billing provider infoPHC-FORT MOHAVE INC
FORT MOHAVE, AZ 86426
FORT MOHAVE, AZ 86426
33aNPI1811086994assigned 10/12/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$19.95M
24GClaims411,543
24DCodes billed188
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Arizona
Rank by total paid#27 of 78
Median peer was paid$12.21M
This provider vs. median1.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 71,423 | $2.98M | |
| 2019 | 62,096 | $2.89M | |
| 2020 | 51,676 | $2.45M | |
| 2021 | 60,106 | $2.87M | |
| 2022 | 63,747 | $3.33M | |
| 2023 | 64,360 | $3.34M | |
| 2024incomplete | 38,135 | $2.10M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 23% | 18,183 | 16,200 | $4.49M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 22% | 20,531 | 19,109 | $4.40M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 10% | 6,945 | 5,937 | $2.02M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 10% | 3,201 | 2,971 | $2.01M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 7.4% | 2,894 | 2,672 | $1.47M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5.3% | 7,855 | 7,494 | $1.05M |
| 70450 | Computed tomography, head or brain; without contrast material | 4.6% | 3,433 | 3,147 | $922K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1.9% | 1,215 | 492 | $382K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.8% | 5,226 | 1,645 | $364K |
| 72125 | Computed tomography, cervical spine; without contrast material | 1.6% | 771 | 723 | $310K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.1% | 2,262 | 2,076 | $229K |
| 71046 | Radiologic examination, chest; 2 views | 1.1% | 6,052 | 5,779 | $221K |
176 more codes
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 2,114 | $175K |
| G0378 | Hospital observation service, per hour | <1% | 1,053 | $173K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,438 | $136K |
| 72100 | <1% | 1,619 | $128K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 2,326 | $126K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 8,547 | $90K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 6,748 | $82K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 413 | $76K |
| 73562 | <1% | 1,735 | $69K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 607 | $67K |
| 72141 | <1% | 274 | $62K | |
| 73030 | <1% | 1,370 | $47K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 367 | $41K |
| 80053 | Comprehensive metabolic panel | <1% | 22,519 | $38K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 5,079 | $36K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 3,251 | $35K |
| 71250 | <1% | 309 | $34K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 272 | $31K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,745 | $30K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 82 | $29K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 10,095 | $27K |
| 73130 | <1% | 1,770 | $25K | |
| 74019 | <1% | 390 | $25K | |
| 93971 | <1% | 249 | $22K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 9,474 | $21K |
| 74018 | <1% | 1,161 | $20K | |
| 73630 | <1% | 1,641 | $19K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 923 | $19K |
| 71045 | Radiologic examination, chest; single view | <1% | 8,521 | $19K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 2,081 | $19K |
| 76641 | <1% | 147 | $18K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 374 | $17K |
| 72040 | <1% | 449 | $17K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 30 | $16K |
| 73610 | <1% | 831 | $16K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 359 | $15K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 8,696 | $15K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 25,061 | $14K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 468 | $13K |
| 72131 | <1% | 54 | $12K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 555 | $10K |
| 84030 | <1% | 793 | $9K | |
| 87428 | <1% | 2,106 | $9K | |
| 97161 | <1% | 419 | $9K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 103 | $8K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 7,112 | $7K |
| 77080 | <1% | 72 | $7K | |
| 76830 | Ultrasound, transvaginal | <1% | 162 | $6K |
| 73502 | <1% | 435 | $6K | |
| 73110 | <1% | 265 | $6K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 5,601 | $6K |
| 84484 | <1% | 6,940 | $6K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 4,578 | $6K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 248 | $6K |
| 72050 | <1% | 38 | $6K | |
| 71271 | <1% | 152 | $5K | |
| 0450 | Emergency room services | <1% | 112 | $5K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,718 | $5K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 100 | $4K |
| Z7502 | <1% | 124 | $4K | |
| 87430 | <1% | 3,129 | $4K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,433 | $4K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,877 | $3K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 6,695 | $3K |
| 83880 | <1% | 3,282 | $3K | |
| 83690 | <1% | 6,518 | $3K | |
| 87420 | <1% | 1,641 | $3K | |
| 76770 | <1% | 58 | $3K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 31 | $2K |
| 81025 | <1% | 4,594 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,893 | $2K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 746 | $2K |
| 59025 | Fetal non-stress test | <1% | 107 | $2K |
| J1815 | Injection, insulin, per 5 units | <1% | 526 | $2K |
| 85730 | <1% | 3,926 | $2K | |
| 85610 | <1% | 8,129 | $2K | |
| 81001 | <1% | 7,024 | $2K | |
| 85379 | <1% | 1,259 | $2K | |
| 83605 | <1% | 2,372 | $2K | |
| 72114 | <1% | 17 | $2K | |
| 87070 | <1% | 972 | $2K | |
| 87040 | <1% | 1,420 | $2K | |
| 76801 | <1% | 12 | $2K | |
| 87088 | <1% | 5,663 | $2K | |
| 84703 | <1% | 1,920 | $1K | |
| 76536 | <1% | 25 | $1K | |
| 84702 | <1% | 434 | $1K | |
| 81003 | <1% | 8,941 | $1K | |
| 87276 | <1% | 3,054 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,056 | $1K |
| 82962 | <1% | 3,747 | $1K | |
| 87186 | <1% | 1,320 | $1K | |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | <1% | 36 | $1K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,860 | $1K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,851 | $986.69 |
| 10060 | <1% | 13 | $961.67 | |
| 80061 | Lipid panel | <1% | 1,251 | $931.35 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 721 | $915.88 |
| 90715 | <1% | 504 | $876.19 | |
| 87081 | <1% | 1,861 | $850.30 | |
| 83735 | <1% | 2,258 | $840.01 | |
| 99070 | <1% | 132 | $795.44 | |
| 87275 | <1% | 3,055 | $766.09 | |
| 82803 | <1% | 180 | $705.14 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 3,301 | $703.00 |
| Z7610 | <1% | 51 | $671.93 | |
| 72110 | <1% | 14 | $658.24 | |
| 82553 | <1% | 1,468 | $600.71 | |
| 86850 | <1% | 1,351 | $580.68 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 7,865 | $574.38 |
| 74022 | <1% | 44 | $549.05 | |
| 72170 | <1% | 54 | $513.25 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,515 | $482.64 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 6,701 | $464.89 |
| 82550 | <1% | 1,460 | $358.29 | |
| 73560 | <1% | 16 | $326.16 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 295 | $300.70 |
| 82150 | <1% | 1,196 | $278.16 | |
| 87077 | <1% | 1,306 | $267.73 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 3,089 | $229.08 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 71 | $212.09 |
| 96376 | <1% | 1,396 | $211.46 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 2,056 | $189.22 |
| 86901 | <1% | 1,356 | $128.32 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 1,606 | $125.97 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 4,488 | $108.47 |
| 96368 | <1% | 187 | $104.26 | |
| 86140 | <1% | 284 | $88.77 | |
| 86900 | <1% | 1,357 | $88.19 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 8,254 | $86.71 |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 953 | $82.84 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 497 | $79.17 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 857 | $69.85 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 316 | $63.15 |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 12 | $51.28 |
| 84100 | <1% | 304 | $49.84 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | <1% | 122 | $39.31 |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 430 | $33.12 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 420 | $33.06 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 773 | $31.21 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 905 | $29.24 |
| J2470 | Injection, pantoprazole sodium, 40 mg | <1% | 74 | $26.86 |
| J2704 | Injection, propofol, 10 mg | <1% | 1,641 | $22.60 |
| 73590 | <1% | 13 | $22.36 | |
| 85027 | <1% | 119 | $21.50 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 48 | $18.33 |
| 85652 | <1% | 161 | $16.81 | |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 101 | $16.37 |
| 82728 | <1% | 32 | $13.02 | |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 15 | $11.53 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 273 | $7.97 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 60 | $6.60 |
| 83615 | <1% | 12 | $6.39 | |
| 85007 | <1% | 63 | $5.45 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 40 | $4.93 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 341 | $4.49 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | <1% | 45 | $4.26 |
| 87205 | <1% | 101 | $3.41 | |
| J7510 | Prednisolone oral, per 5 mg | <1% | 166 | $1.31 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 454 | $0.32 |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 66 | $0.30 |
| 29125 | 0% | 50 | $0.00 | |
| 51702 | 0% | 31 | $0.00 | |
| 36600 | 0% | 99 | $0.00 | |
| 82009 | 0% | 15 | $0.00 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 110 | $0.00 |
| 97116 | 0% | 33 | $0.00 | |
| 36416 | 0% | 434 | $0.00 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 17 | $0.00 |
| J1630 | Injection, haloperidol, up to 5 mg | 0% | 13 | $0.00 |
| V2632 | Posterior chamber intraocular lens | 0% | 20 | $0.00 |
| J3411 | Injection, thiamine hcl, 100 mg | 0% | 17 | $0.00 |
| A9270 | Non-covered item or service | 0% | 36 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 57 | $0.00 |
| 12001 | 0% | 12 | $0.00 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLAWRENCE, CHARLOTTE (SECRETARY)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.